Research & Development



  平叟長嘆一聲,就上了馬車,車輪碾著白雪離開了雲家莊園,雲瑯讓孩子們在門口搭建了一個棚子,開始煮香濃的小米粥,那些想要喝粥的人,唯一需要付出的就是幫著掩埋尸體。   “不是,是你無恥的偷看了我家大女沐浴,然後覺得心中有愧,給的一點補償!”aⅴ无码天堂2018在线   嘿嘿嘿,這樣的三姓家奴自然不堪重用,在開國列侯中,他排名第八十六,倒數第二,封戶也只有六百。亚洲天堂a2018无码   說到漆,這東西在大漢實在是太普遍了,這種從漆樹上獲取的汁液,在混合了各種顏料之後就有了把普通東西變成藝術品的神奇功能。   看來他們兄弟的情誼確實豐厚……伊人成人综合   “你舅舅到現在都沒消息嗎?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo